Journal of Applied Physiology AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 96: 931-937, 2004. First published November 7, 2003; doi:10.1152/japplphysiol.00725.2003
8750-7587/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
96/3/931    most recent
00725.2003v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (45)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saunders, P. U.
Right arrow Articles by Hawley, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saunders, P. U.
Right arrow Articles by Hawley, J. A.

Improved running economy in elite runners after 20 days of simulated moderate-altitude exposure

P. U. Saunders,1,2 R. D. Telford,3 D. B. Pyne,1 R. B. Cunningham,4 C. J. Gore,1 A. G. Hahn,1 and J. A. Hawley2

1Department of Physiology and 3Track and Field Program, Australian Institute of Sport, Belconnen, Australian Capital Territory 2616; 4StatWise Pty, Flynn, Australian Capital Territory 2615; and 2Exercise Metabolism Group, School of Medical Sciences, RMIT University, Bundoora, Victoria 3083, Australia

Submitted 14 July 2003 ; accepted in final form 5 November 2003


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
To investigate the effect of altitude exposure on running economy (RE), 22 elite distance runners [maximal O2 consumption (O2) 72.8 ± 4.4 ml·kg-1·min-1; training volume 128 ± 27 km/wk], who were homogenous for maximal O2 and training, were assigned to one of three groups: live high (simulated altitude of 2,000–3,100 m)-train low (LHTL; natural altitude of 600 m), live moderate-train moderate (LMTM; natural altitude of 1,500–2,000 m), or live low-train low (LLTL; natural altitude of 600 m) for a period of 20 days. RE was assessed during three submaximal treadmill runs at 14, 16, and 18 km/h before and at the completion of each intervention. O2, minute ventilation (E), respiratory exchange ratio, heart rate, and blood lactate concentration were determined during the final 60 s of each run, whereas hemoglobin mass (Hbmass) was measured on a separate occasion. All testing was performed under normoxic conditions at ~600 m. O2 (l/min) averaged across the three submaximal running speeds was 3.3% lower (P = 0.005) after LHTL compared with either LMTM or LLTL. E, respiratory exchange ratio, heart rate, and Hbmass were not significantly different after the three interventions. There was no evidence of an increase in lactate concentration after the LHTL intervention, suggesting that the lower aerobic cost of running was not attributable to an increased anaerobic energy contribution. Furthermore, the improved RE could not be explained by a decrease in E or by preferential use of carbohydrate as a metabolic substrate, nor was it related to any change in Hbmass. We conclude that 20 days of LHTL at simulated altitude improved the RE of elite distance runners.

oxygen consumption; intermittent hypoxia


THE EFFECT OF ALTITUDE TRAINING on endurance performance has been researched extensively (24, 8, 15, 18, 19, 22, 2529, 3336, 39, 43). There is a widespread belief in the athletic community that altitude training can enhance sea-level athletic performance (15, 26, 43), with at least three independent studies demonstrating that altitude training increases both sea-level maximal O2 consumption (O2 max) and running performance (8, 26, 36). The mechanisms for these improvements are not clear but have been proposed to include hematological changes (i.e., increased red cell mass) (8, 26) and local muscular adaptations (such as improved skeletal muscle buffer capacity) (19). The traditional approach to altitude training was for athletes to live and train at moderate natural altitude. A recent approach has been for athletes to live and sleep at altitude and train near sea level, i.e., the so-called live high-train low (LHTL) method (26). Because the geography of many countries does not readily permit LHTL, a further refinement has been for athletes to live at simulated altitude under normobaric conditions and train at, or close to, sea level (34).

Altitude acclimatization results in both central and peripheral adaptations, which improve O2 delivery and utilization (6, 28, 38, 45); decreased O2 utilization for a given speed would improve an athlete's running economy (RE). Potential mechanisms for improved RE are the amount of ATP per mole O2 used increases, the amount of ATP necessary for running at a given speed decreases, or a combination of both of these mechanisms (22). To date, little research has been undertaken on the effects of altitude exposure on RE in highly trained distance runners. Two investigations (26, 39) have reported no change in submaximal O2 consumption (O2) after a period of altitude exposure, whereas another (25) found improved RE after intermittent hypoxic altitude exposure. Similarly, after a period of altitude acclimatization, sea-level O2 during submaximal cycling is either reduced (19, 22, 23, 27) or unchanged (5, 33). Therefore, it appears that, in both running and cycling, altitude exposure certainly has no detrimental effects on economy and, in some athletes, may lead to improvements. To the best of our knowledge, only one study has demonstrated an improved RE in well-trained runners as a result of altitude training (25). Improving RE is advantageous to distance-running performance because it reduces the utilization of O2 at any given steady-state running speed (9, 1113, 40). Previous studies demonstrating improved economy as a result of altitude exposure have used cycling or two-legged kicking as the mode of exercise, and subjects were mountain climbers and triathletes (19, 22, 23, 27). Furthermore, these investigations used natural or simulated altitudes ranging from 3,000 m (19) to 6,194 m (22, 27), which are generally higher than altitudes typically used by athletes. Therefore, the present investigation was undertaken to determine the effects of altitude exposure on RE in elite distance runners. We hypothesized that RE would be improved after both natural moderate [live moderate-train moderate (LMTM)] and simulated altitude (LHTL).


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
Subjects. Twenty-two elite male middle- and long-distance runners volunteered to participate in this study. Subjects all competed at a national (n = 12) or international (n = 10) level (Table 1). They were informed of the experimental procedures and possible risks involved with participation before written consent was obtained. The Australian Institute of Sport Ethics Committee approved all testing procedures.


View this table:
[in this window]
[in a new window]
 
Table 1. Subject characteristics

 

Overview of experimental protocol. The study was a between- and within-subject repeated-measures design with a nested temporal design within subjects. Subjects were assigned to three different intervention groups, with each group homogenous in regard to O2 max and training (Table 1). Ten subjects were assigned to the LHTL group, consisting of 4 wk at simulated altitude that ranged from 2,000 to 3,100 m (Table 2). During this period, subjects spent 5 nights/wk (9–12 h/night) in a normobaric hypoxic chamber with N2 enrichment and 2 nights/wk at the ambient altitude (~600 m) during the 4-wk period. Ten subjects were assigned to the LMTM group. The LMTM intervention was performed at Falls Creek, Victoria, Australia (1,570 m) for a period of 20 days, with training altitudes that ranged from 1,500 to 2,000 m. The LMTM intervention took place 6 wk after the completion of the LHTL intervention, and subjects in this group were also part of the LHTL (n = 6) or control groups (n = 1). The control group [live low-train low (LLTL)] consisted of 13 runners who lived and trained near sea level (600 m) for a period of 20 days. Subjects in the control group were tested within the 12-wk period that the other interventions occurred, with subjects in this group also being part of the LHTL (n = 1) and LMTM (n = 1). The fact that some subjects were included in more than one intervention group was factored into the subsequent statistical analysis. A washout period of 6 wk was used for subjects in multiple groups. Before and on completion of the three interventions, all subjects performed testing under normoxic conditions in Canberra, ACT, Australia (600 m). RE was measured at three submaximal speeds (see Treadmill testing), with O2 max measured during the baseline test. Hemoglobin mass (Hbmass) was determined by carbon monoxide (CO) rebreathing on a separate occasion to the submaximal RE test.


View this table:
[in this window]
[in a new window]
 
Table 2. LHTL simulated altitude protocol

 

Treadmill testing. RE was determined by measuring submaximal O2 for 4 min at constant running speeds of 14, 16, and 18 km/h on a custom-built motorized treadmill (Australian Institute of Sport, Belconnen, Australia). O2, minute ventilation (E), respiratory exchange ratio (RER), heart rate (HR), and blood lactate concentration ([Lac]) were measured during the RE tests. RE was defined as the total O2 collected during the last 60 s of each 4-min running stage. The slope of O2 vs. running speed was also determined as a measure of RE. O2 max was measured during an incremental test to volitional exhaustion, which was performed 2 min after the third submaximal effort. Subjects completed an incremental protocol that commenced at a treadmill speed of 18 km/h and was increased 1 km/h each minute up to a speed of 20 km/h. After 1 min at 20 km/h (0% gradient), the treadmill gradient increased by 1% each minute until volitional exhaustion was reached. HR was measured by short-range telemetry (Polar Vantage NV, Kempele, Finland), and on immediate completion of the test a capillary blood sample was drawn for measurement of [Lac].

Gas analysis. Respiratory gases were analyzed on a custom-designed and -built open-circuit indirect calorimetry system with associated in-house software (Australian Institute of Sport, Belconnen, Australia). This automated system uses the Douglas bag principle (16) to collect all expirate into one of two 150-liter aluminized bags. While one bag is being filled, the other has the expired volume and gas fractions determined. Standard algorithms were employed to compute minute values of E, expired CO2, O2, and RER from the sum of two consecutive 30-s samples. The O2 and CO2 gas analyzers (AEI Technologies, Pittsburgh, PA) were calibrated before each test with three precision gas mixtures, with an acceptable calibration being within ±0.03% of all target values. Volume was measured with a precision-calibrated linear displacement piston coupled to real-time measurement of temperature and pressure inside the piston. The typical error of measurement (24) or standard deviation of the differences divided by square root of two for O2 in our laboratory is 2.4% for the pooled data for running at 14, 16, and 18 km/h. Typical error of measurement was established from duplicate trials conducted on 11 subjects before the start of the main study.

Hbmass. Before and after the three experimental periods, one-half of each group of runners underwent measurement of total Hbmass by using a CO-rebreathing technique modified from Burge and Skinner (7). The alterations used two doses of 99.5% CO, which were rebreathed for 10 min each (20-ml initial dose and a second dose of 1.25 ml CO/kg body mass), and percent HbCO (%HbCO) was measured on capillary instead of venous blood (1). An average of %HbCO of four capillary blood samples determined on an ABL700 Series blood-gas analyzer (Radiometer Medical, Copenhagen, Denmark) for both CO doses was obtained, and the change in %HbCO (difference between first and second measures) was used to calculate Hbmass (7). Typical error of measurement for Hbmass in our laboratory is 2.7% (1) when capillary blood samples are used.

Statistical analysis. Because some individuals participated in multiple groups, the design was not fully balanced. Consequently, a general linear mixed-model analysis ({chi}2 test) was undertaken. Mean profiles along with the standard errors are shown graphically, and the amount of variability between groups is given by the least significant difference. Any pair of means differing by more than the least significant difference are considered significant (P < 0.05) changes between pre- and posttests among the three treatment groups. Means are pooled values of the three running speeds, because differences were independent of speed, indicated by no group x test x speed interaction. The statistical package Genstat (2003) sixth edition (VSN International, Oxford, UK) was employed for statistical computation. Slopes and intercepts of O2 vs. running speed were compared on group mean data by using Prism software (2002) version 3.03 (GraphPad Software, San Diego, CA). The regression data for the three groups were fitted through the measured O2 at 14, 16, and 18 km/h, as well as an assumed value of 0.304 l/min (LHTL only) for standing (0 km/h) O2 on the basis of existing data (20, 32, 37).


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
RE. O2 was similar across the three groups during the pretest with means ± SD of 3.53 ± 0.51 (LHTL), 3.51 ± 0.34 (LMTM), and 3.47 ± 0.36 (LLTL) l/min, respectively, for the pooled data of the three running speeds. However, 20 days of LHTL simulated-altitude exposure decreased (3.3%, P = 0.005) O2 to 3.41 ± 0.53 l/min, whereas the LMTM and LLTL groups remained unchanged with posttest means ± SD of 3.50 ± 0.32 and 3.49 ± 0.37 l/min, respectively (Fig. 1). The reduction in O2 during the LHTL intervention was present at all three running speeds (Fig. 2). There were no significant differences between the slopes of O2 vs. running speed pre- and postintervention for the three groups. However, the LHTL slope was offset after the 20-day altitude exposure (Fig. 3). When the LHTL slopes were compared after adjusting for the estimated standing O2 by the same absolute (0.12 l/min) and percent (3.4%) change observed during the three running speeds, there was still no significant difference in the slopes between pre- and posttests (Table 3). We calculated that a 17% reduction in running and standing O2 was required to make the pre- and postintervention slopes significantly different.



View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1. Absolute oxygen consumption (O2; in l/min) before (pre) and after (post) 20 days of altitude exposure, averaged across 3 running speeds (14, 16, and 18 km/h). Values are means ± SE; n = 10 [live high-train low at simulated high altitude (LHTL)], n = 10 [live and train at natural moderate altitude (LMTM)], and n = 13 [live and train at natural low altitude (LLTL; 600 m)]. Changes between pre- and posttests are significantly different (P < 0.05) among the 3 treatment groups, signified by the least significant difference (LSD), which is 2 times the standard error of the differences.

 


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2. Change in absolute O2 (l/min) at 3 running speeds (14, 16, and 18 km/h) after 20 days of altitude exposure. Values are individual responses as well as mean responses for each intervention; mean values are represented with a thicker line and different shade as individuals; n = 10 (LHTL; A), n = 10 (LMTM; B), and n = 13 (LLTL; C).

 


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 3. Comparison of absolute O2 (l/min) with speed (km/h) between preand posttest for the LHTL (A), LMTM (B), and LLTL (C) groups. Slope equations and r2 values are given for each slope as well as the t and P values for the comparison of pre- and posttest slopes for the 3 groups.

 

View this table:
[in this window]
[in a new window]
 
Table 3. Comparison of O2 vs. speed slopes pre- and post-LHTL intervention with estimated adjustments to standing O2

 

Cardiorespiratory and physiological measures. When the three groups were compared between pre- and posttests across the three running speeds, E (P = 0.89), HR (P = 0.31), RER (P = 0.48), and Hbmass (P = 0.22) remained unchanged (Table 4). The log of [Lac] was taken because initial analysis showed this measure was not normally distributed. The difference between pre- and posttests for log of [Lac] for the three groups (pooled data of the 3 running speeds) was not significant (P = 0.12). However, the LHTL group showed a trend toward decreased (24%, P = 0.12) [Lac] after the altitude exposure with the pretest value of 2.5 ± 1.1 mM decreasing to 2.1 ± 1.2 mM. [Lac] in the other groups was unchanged, with pooled values of 2.1 ± 1.2 to 2.0 ± 1.0 mM (LMTM) and 3.0 ± 1.3 to 2.8 ± 1.3 mM (LLTL) between pre- and posttests, respectively (Fig. 4).


View this table:
[in this window]
[in a new window]
 
Table 4. Cardiorespiratory and physiological measures

 


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 4. Log of blood lactate concentration before (pre) and after (post) 20 days of altitude exposure, averaged across 3 running speeds (14, 16, and 18 km/h). Values are means ± SE; n = 10 (LHTL), n = 10 (LMTM), and n = 13 (LLTL). LSD is 2 times the standard error of the differences; any pair of means differing by more than the LSD are considered significant (P < 0.05) changes between pre- and posttests among the 3 treatment groups.

 


    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
The major finding from the present study was that 20 nights of sleeping at 2,000- to 3,100-m simulated altitude while training at 600-m altitude (LHTL) reduced whole body O2 (i.e., improved RE) in elite distance runners compared with a control group who lived and trained near sea level (LLTL). To the best of our knowledge, this is the first investigation to find improvements in RE (i.e., reductions in submaximal O2 cost of running) in elite athletes after short-term exposure to simulated moderate altitude. Of interest was the observation that RE was improved over a range of running speeds (14, 16, and 18 km/h) and was independent of changes in Hbmass, E, RER, and HR. A second important finding of the present study was that living at 1,500 m and training at an altitude of ~2,000 m was insufficient stimulus to alter variables associated with RE.

Our results are not in accordance with the conventional view that submaximal O2 remains unchanged at sea level after returning from a period of altitude exposure, with multiple studies observing no change in submaximal O2 at sea level (21, 26, 29, 39, 44), nor even changes in submaximal O2 under chronic hypoxic conditions up to 7,440-m terrestrial altitude (31). However, Katayama et al. (25) have previously reported that simulated-altitude exposure (3-wk exposure comprising 3 sessions/wk for 90 min/session of intermittent hypobaria of 4,500 m) improved RE in highly trained runners. Indeed, our findings are consistent with a growing number of studies that have shown that various forms of altitude exposure can reduce submaximal O2 (19, 22, 23, 25, 27). These exposures include mountain climbing over 3 wk to 6,194 m (22, 27), 23-night exposure to 3,000-m simulated altitude (19), 3-wk exposure to intermittent hypobaria of 4,500 m (25), and long-term residence at 4,200 m (23). A rigorous experimental design as well as good precision in our indirect calorimetry system give us confidence in our data.

Mechanisms that have been suggested to improve economy after altitude exposure include a decreased cost of E (22). In the present study, E and HR did not markedly change after 20 days of LHTL simulated-altitude exposure, suggesting that the increase in RE was not strongly associated with these parameters. A potential mechanism that could conceivably improve economy is greater carbohydrate utilization for oxidative phosphorylation after a period of altitude acclimatization. It has previously been observed that 4,300-m altitude acclimatization for 21 days decreased the reliance on fat as a fuel at both rest and during low-intensity (50% O2 max) cycling (33). It has been suggested that a shift toward increased dependence on glucose metabolism and away from reliance on fatty acid consumption under conditions of acute and chronic hypoxia is advantageous because glucose is a more efficient fuel in terms of generating ATP per mole of O2 (5, 19, 22). In the present study, there was no evidence to support a shift toward greater carbohydrate utilization during submaximal exercise, because RER was not different between the three groups. Another potential mechanism underlying the improved economy is a reduced energy requirement of one or more processes involved in excitation and contraction of the working muscles as a result of metabolic adaptations associated with altitude acclimatization (22). However, such a hypotheses was not tested in the present investigation.

There was no significant difference in [Lac] after LHTL altitude exposure, which suggests that the improved RE demonstrated in the present study was not a result of an increased anaerobic energy contribution. One of the potential mechanisms for lower plasma [Lac] accumulation is an increase in skeletal muscle oxidative enzyme capacity (17), with a resultant shift in metabolism away from anaerobic toward aerobic. Weston et al. (42) reported that Kenyan runners who live and train at altitude have higher oxidative enzyme activities than their O2 max-matched Caucasian runners and that this is associated with a better RE. On the other hand, Van Hall and associates (41) demonstrated that reduced peak [Lac] may be a transient phenomenon, with lower levels merely reflecting a disturbance to muscle acid-base balance.

The slope between O2 and running speed and power output has been used as a means of detecting changes in economy (22). The failure to observe any significant differences in the slopes for either of the hypoxia groups implies that the enhancement in RE is not directly attributable to improved locomotor muscle metabolism or that more invasive procedures are required to detect this change. At muscle level, a reduced ATP cost of contraction should coincide with a change in slope of the O2 vs. speed relationship. The same is true for a better ATP yield per mole of O2 used. If the improved RE is not occurring at a muscular level, it may simply reflect a decreased resting metabolism by an unknown mechanism.

RE did not change after the LMTM intervention at natural moderate altitude (1,500–2,000 m). One plausible explanation for this finding is that the altitude employed in the LMTM intervention was insufficient to stimulate the mechanism(s) responsible for inducing whole body improvements in economy. Previous research demonstrating improved economy as a result of altitude exposure (19, 22, 23, 25, 27) has utilized markedly higher elevations (3,000–6,200 m). In the present study, the LHTL intervention, which resulted in improved RE, was conducted at an elevation between 2,000 and 3,100 m. Although further work is clearly required to elucidate the dose-response relationship in terms of altitude and duration of exposure, the results of the present study suggest that a "threshold altitude" to alter economy might exist and may be between 2,000 and 3,100 m.

In agreement with previous investigations from our laboratory (24) that demonstrated no change in Hbmass or erythrocyte production after LHTL, we did not detect any significant changes in Hbmass after any intervention. This is in contrast to the results of studies conducted by others (8, 26). It is possible that 20 days of 8–12 h/day altitude exposure to 2,000–3,200 m is insufficient time to elicit marked increases in red cell mass. However, we have also been unable to detect an increase after a 31-day training camp at 2,690 m (18). It may well be that longer periods at these altitudes are required to elicit changes in Hbmass. Indeed, evidence suggests that cyclists living permanently at 2,600 m have a higher Hbmass than their sea-level counterparts (35). In the present study, which investigates the effects of altitude exposure on RE, it is apparent that Hbmass has no relationship with the improved RE demonstrated.

Despite our finding of no changes in Hbmass, there are other potential benefits arising from short-term altitude exposure. Improved RE is a critical part of improving running performance, the ultimate goal of athletes using altitude and hypoxia. Although we did not determine performance per se in the present study, the relationship between RE and performance is well documented, with many independent reports demonstrating a strong relationship between RE and distance-running performance (912, 14, 30). Of note, but by no means conclusive evidence, is that all of the subjects (apart from 2 who did not race during the duration of the study) ran personal or season best times over distances ranging from 1,500 to 10,000 m within 1 mo of the LHTL intervention. In comparison, only 3 of the 13 LLTL subjects ran personal or season best times within 1 mo of the control intervention.

In conclusion, the results of the present study demonstrate that sleeping at a simulated altitude of 2,000–3,100 m using the LHTL model for 20 days resulted in a 3.3% improvement in RE of elite distance runners, whereas living and training at moderate altitude (1,500–2,000 m) and living and training near sea level (600 m) for the same duration had no effect on RE in elite distance runners. The underlying mechanisms for the reduction in submaximal O2 cost after LHTL are difficult to elucidate but were not related to E, HR, RER, or Hbmass. The lack of change in Hbmass strongly suggests that the mechanism(s) underlying the enhanced RE is independent of accelerated erythropoiesis. Finally, our results suggest that 20 days of LHTL are sufficient time to acquire benefits from altitude acclimatization, although the elevation must be >2,000 m to provide sufficient stimulus to improve RE.


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
The authors acknowledge J. Woodside, N. Townsend, G. Allbon, S. Wright, and A. Cox for technical assistance during data collection; E. Lawton, R. Shugg, A. Martin, and M. Steinebronn of the Department of Physiology, Australian Institute of Sport, for support in operating the altitude house; and BOC Gases Australia for technical support.

GRANTS

This study was funded by the Australian Sports Commission.


    FOOTNOTES
 

Address for reprint requests and other correspondence: J. A. Hawley, School of Medical Sciences, RMIT Univ., PO Box 71, Bundoora, Victoria 3083, Australia (E-mail: john.hawley{at}rmit.edu.au).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 

  1. Ashenden MJ, Gore CJ, Burge CM, Clough ML, Bourdon PC, Dobson GP, and Hahn AG. Skin-prick blood samples are reliable for estimating Hb mass with the CO-dilution technique. Eur J Appl Physiol Occup Physiol 79: 535-537, 1999.
  2. Ashenden MJ, Gore CJ, Dobson GP, Boston TT, Parisotto R, Emslie KR, Trout GJ, and Hahn AG. Simulated moderate altitude elevates serum erythropoietin but does not increase reticulocyte production in well-trained runners. Eur J Appl Physiol 81: 428-435, 2000.
  3. Ashenden MJ, Gore CJ, Dobson GP, and Hahn AG. "Live high, train low" does not change the total haemoglobin mass of male endurance athletes sleeping at a simulated altitude of 3,000 m for 23 nights. Eur J Appl Physiol Occup Physiol 80: 479-484, 1999.
  4. Ashenden MJ, Gore CJ, Martin DT, Dobson GP, and Hahn AG. Effects of a 12-day "live high, train low" camp on reticulocyte production and haemoglobin mass in elite female road cyclists. Eur J Appl Physiol Occup Physiol 80: 472-478, 1999.
  5. Brooks GA, Butterfield GE, Wolfe RR, Groves BM, Mazzeo RS, Sutton JR, Wolfel EE, and Reeves JT. Increased dependence on blood glucose after acclimatization to 4,300 m. J Appl Physiol 70: 919-927, 1991.
  6. Brooks GA, Wolfel EE, Groves BM, Bender PR, Butterfield GE, Cymerman A, Mazzeo RS, Sutton JR, Wolfe RR, and Reeves JT. Muscle accounts for glucose disposal but not blood lactate appearance during exercise after acclimatization to 4,300 m. J Appl Physiol 72: 2435-2445, 1992.
  7. Burge CM and Skinner SL. Determination of hemoglobin mass and blood volume with CO: evaluation and application of a method. J Appl Physiol 79: 623-631, 1995.
  8. Burtscher M, Nachbauer W, Baumgartl P, and Philadelphy M. Benefits of training at moderate altitude versus sea level training in amateur runners. Eur J Appl Physiol Occup Physiol 74: 558-563, 1996.
  9. Conley DL and Krahenbuhl GS. Running economy and distance running performance of highly trained athletes. Med Sci Sports Exerc 12: 357-360, 1980.
  10. Conley DL, Krahenbuhl GS, Burkett LN, and Millar AL. Following Steve Scott: physiological changes accompanying training. Phys Sports Med 12: 103-106, 1984.
  11. Costill DL. The relationship between selected physiological variables and distance running performance. J Sports Med Phys Fitness 7: 61-66, 1967.
  12. Costill DL, Thomason H, and Roberts E. Fractional utilization of the aerobic capacity during distance running. Med Sci Sports 5: 248-252, 1973.
  13. Daniels JT. A physiologist's view of running economy. Med Sci Sports Exerc 17: 332-338, 1985.
  14. Di Prampero PE, Capelli C, Pagliaro P, Antonutto G, Girardis M, Zamparo P, and Soule RG. Energetics of best performances in middle-distance running. J Appl Physiol 74: 2318-2324, 1993.
  15. Dick FW. Training at altitude in practice. Int J Sports Med 13: 203-206, 1992.
  16. Douglas CG. A method for determining the total respiratory exchange in man. J Physiol 42: 17-18, 1911.
  17. Gollnick PD and Saltin B. Significance of skeletal muscle oxidative enzyme enhancement with endurance training. Clin Physiol 2: 1-12, 1982.
  18. Gore CJ, Hahn A, Rice A, Bourdon P, Lawrence S, Walsh C, Stanef T, Barnes P, Parisotto R, Martin D, Pyne D, and Gore C. Altitude training at 2,690 m does not increase total haemoglobin mass or sea level O2 max in world champion track cyclists. J Sci Med Sport 1: 156-170, 1998.
  19. Gore CJ, Hahn AG, Aughey RJ, Martin DT, Ashenden MJ, Clark SA, Garnham AP, Roberts AD, Slater GJ, and McKenna MJ. Live high: train low increases muscle buffer capacity and submaximal cycling effi-ciency. Acta Physiol Scand 173: 275-286, 2001.
  20. Gore CJ and Withers RT. Effect of exercise intensity and duration on postexercise metabolism. J Appl Physiol 68: 2362-2368, 1990.
  21. Grassi B, Marzorati M, Kayser B, Bordini M, Colombini A, Conti M, Marconi C, and Cerretelli P. Peak blood lactate and blood lactate vs. workload during acclimatization to 5,050 m and in deacclimatization. J Appl Physiol 80: 685-692, 1996.
  22. Green HJ, Roy B, Grant S, Hughson R, Burnett M, Otto C, Pipe A, McKenzie D, and Johnson M. Increases in submaximal cycling effi-ciency mediated by altitude acclimatization. J Appl Physiol 89: 1189-1197, 2000.
  23. Hochachka PW, Stanley C, Matheson GO, McKenzie DC, Allen PS, and Parkhouse WS. Metabolic and work efficiencies during exercise in Andean natives. J Appl Physiol 70: 1720-1730, 1991.
  24. Hopkins WG. Measures of reliability in sports medicine and science. Sports Med 30: 1-15, 2000.
  25. Katayama K, Matsuo M, Ishida K, Mori S, and Miyamura M. Intermittent hypoxia improves endurance performance and submaximal efficiency. High Alt Med Biol 4: 291-304, 2003.
  26. Levine BD and Stray-Gundersen J. "Living high-training low": effect of moderate-altitude acclimatization with low-altitude training on performance. J Appl Physiol 83: 102-112, 1997.
  27. MacDonald MJ, Green HJ, Naylor HL, Otto C, and Hughson RL. Reduced oxygen uptake during steady state exercise after 21-day mountain climbing expedition to 6,194 m. Can J Appl Physiol 26: 143-156, 2001.
  28. Mairbaurl H, Schobersberger W, Humpeler E, Hasibeder W, Fischer W, and Raas E. Beneficial effects of exercising at moderate altitude on red cell oxygen transport and on exercise performance. Pflügers Arch 406: 594-599, 1986.
  29. Piehl Aulin K, Svedenhag J, Wide L, Berglund B, and Saltin B. Short-term intermittent normobaric hypoxia— haematological, physiological and mental effects. Scand J Med Sci Sports 8: 132-137, 1998.
  30. Pollock ML. Submaximal and maximal working capacity of elite distance runners. Part I: Cardiorespiratory aspects. Ann NY Acad Sci 301: 310-322, 1977.
  31. Pugh LG, Gill MB, Lahiri S, Milledge JS, Ward MP, and West JB. Muscular exercise at great altitudes. J Appl Physiol 19: 431-440, 1964.
  32. Richardson DT, Campbell W, Morrison R, and Ford JF. Report of the Investigation of the Energy Expenditure of the British Soldier in India. Calcutta, India: Government of India Press, 1927.
  33. Roberts AC, Butterfield GE, Cymerman A, Reeves JT, Wolfel EE, and Brooks GA. Acclimatization to 4,300-m altitude decreases reliance on fat as a substrate. J Appl Physiol 81: 1762-1771, 1996.
  34. Rusko HR. New aspects of altitude training. Am J Sports Med 24: 48-52, 1996.
  35. Schmidt W, Heinicke K, Rojas J, Manuel Gomez J, Serrato M, Mora M, Wolfarth B, Schmid A, and Keul J. Blood volume and hemoglobin mass in endurance athletes from moderate altitude. Med Sci Sports Exerc 34: 1934-1940, 2002.
  36. Stray-Gundersen J, Chapman RF, and Levine BD. "Living high-training low" altitude training improves sea level performance in male and female elite runners. J Appl Physiol 91: 1113-1120, 2001.
  37. Strickland SS and Ulijaszek SJ. Energetic cost of standard activities in Gurkha and British soldiers. Ann Hum Biol 17: 133-144, 1990.
  38. Sutton JR, Reeves JT, Wagner PD, Groves BM, Cymerman A, Malconian MK, Rock PB, Young PM, Walter SD, and Houston CS. Operation Everest II: oxygen transport during exercise at extreme simulated altitude. J Appl Physiol 64: 1309-1321, 1988.
  39. Telford RD, Graham KS, Sutton JR, Hahn AG, Campbell DA, Creighton SW, Cunningham RB, Davis PG, Smith JA, and Tumilty D. Medium altitude training and sea level performance (Abstract). Med Sci Sports Exerc 28: S124, 1996.
  40. Thomas DQ, Fernhall B, and Grant H. Changes in running economy during a 5-km run in trained men and women runners. J Strength Cond Res 13: 162-167, 1999.
  41. Van Hall G, Calbet JA, Sondergaard H, and Saltin B. The reestablishment of the normal blood lactate response to exercise in humans after prolonged acclimatization to altitude. J Physiol 536: 963-975, 2001.
  42. Weston AR, Karamizrak O, Smith A, Noakes TD, and Myburgh KH. African runners exhibit greater fatigue resistance, lower lactate accumulation, and higher oxidative enzyme activity. J Appl Physiol 86: 915-923, 1999.
  43. Wilber R. Altitude training for the enhancement of sea level endurance performance. Olympic Coach 5: 6-10, 1995.
  44. Wolfel EE, Groves BM, Brooks GA, Butterfield GE, Mazzeo RS, Moore LG, Sutton JR, Bender PR, Dahms TE, McCullough RE, et al. Oxygen transport during steady-state submaximal exercise in chronic hypoxia. J Appl Physiol 70: 1129-1136, 1991.
  45. Young AJ, Evans WJ, Cymerman A, Pandolf KB, Knapik JJ, and Maher JT. Sparing effect of chronic high-altitude exposure on muscle glycogen utilization. J Appl Physiol 52: 857-862, 1982.



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
M. J. Truijens, F. A. Rodriguez, N. E. Townsend, J. Stray-Gundersen, C. J. Gore, and B. D. Levine
The effect of intermittent hypobaric hypoxic exposure and sea level training on submaximal economy in well-trained swimmers and runners
J Appl Physiol, February 1, 2008; 104(2): 328 - 337.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
F. A. Rodriguez, M. J. Truijens, N. E. Townsend, J. Stray-Gundersen, C. J. Gore, and B. D. Levine
Performance of runners and swimmers after four weeks of intermittent hypobaric hypoxic exposure plus sea level training
J Appl Physiol, November 1, 2007; 103(5): 1523 - 1535.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
J. Rubenson, D. B. Heliams, S. K. Maloney, P. C. Withers, D. G. Lloyd, and P. A. Fournier
Reappraisal of the comparative cost of human locomotion using gait-specific allometric analyses
J. Exp. Biol., October 15, 2007; 210(20): 3513 - 3524.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Neya, T. Enoki, Y. Kumai, T. Sugoh, and T. Kawahara
The effects of nightly normobaric hypoxia and high intensity training under intermittent normobaric hypoxia on running economy and hemoglobin mass
J Appl Physiol, September 1, 2007; 103(3): 828 - 834.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. P. Dufour, E. Ponsot, J. Zoll, S. Doutreleau, E. Lonsdorfer-Wolf, B. Geny, E. Lampert, M. Fluck, H. Hoppeler, V. Billat, et al.
Exercise training in normobaric hypoxia in endurance runners. I. Improvement in aerobic performance capacity
J Appl Physiol, April 1, 2006; 100(4): 1238 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
B Roels, P Hellard, L Schmitt, P Robach, J-P Richalet, and G P Millet
Is it more effective for highly trained swimmers to live and train at 1200 m than at 1850 m in terms of performance and haematological benefits?
Br. J. Sports Med., February 1, 2006; 40(2): e4 - e4.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Keslacy, R. S. Mazzeo, D. A. Giussani, A. S. Thakor, G. Insalaco, M. R. Bonsignore, F. A. Rodriguez, K. S. Mark, C. Reboul, S. Tanguy, et al.
Commentary on Point-Counterpoint
J Appl Physiol, January 1, 2006; 100(1): 363 - 363.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. V. Brugniaux, L. Schmitt, P. Robach, G. Nicolet, J.-P. Fouillot, S. Moutereau, F. Lasne, V. Pialoux, P. Saas, M.-C. Chorvot, et al.
Eighteen days of "living high, training low" stimulate erythropoiesis and enhance aerobic performance in elite middle-distance runners
J Appl Physiol, January 1, 2006; 100(1): 203 - 211.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. D. Noakes, P. E. di Prampero, C. Capelli, T. Zaobornyj, L. B Valdez, A. Boveris, M. Ashenden, T. W. Secomb, S. Dufour, E. Ponsot, et al.
Comments on Point:Counterpoint "Positive effects of intermittent hypoxia (live high:train low) on exercise performance are/are not mediated primarily by augmented red cell volume"
J Appl Physiol, December 1, 2005; 99(6): 2453 - 2462.
[Full Text] [PDF]


Home page
J. Physiol.Home page
C. Marconi, M. Marzorati, D. Sciuto, A. Ferri, and P. Cerretelli
Economy of locomotion in high-altitude Tibetan migrants exposed to normoxia
J. Physiol., December 1, 2005; 569(2): 667 - 675.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. J Gore and W. G Hopkins
Counterpoint: Positive effects of intermittent hypoxia (live high:train low) on exercise performance are not mediated primarily by augmented red cell volume
J Appl Physiol, November 1, 2005; 99(5): 2055 - 2057.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
REBUTTAL FROM DRS. LEVINE AND STRAY-GUNDERSEN
J Appl Physiol, November 1, 2005; 99(5): 2057 - 2057.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. J. Gore, W. G. Hopkins, and C. M. Burge
Errors of measurement for blood volume parameters: a meta-analysis
J Appl Physiol, November 1, 2005; 99(5): 1745 - 1758.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. F. Coyle
Improved muscular efficiency displayed as Tour de France champion matures
J Appl Physiol, June 1, 2005; 98(6): 2191 - 2196.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
96/3/931    most recent
00725.2003v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (45)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saunders, P. U.
Right arrow Articles by Hawley, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saunders, P. U.
Right arrow Articles by Hawley, J. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.